Stay updated on Ertugliflozin in Pediatric T2DM Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.

Latest updates to the Ertugliflozin in Pediatric T2DM Clinical Trial page
- Check5 days agoChange DetectedRecord History shows a 2025-10-31 update with Results Posted and related data (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and an updated Study Status. The prior 2025-05-29 entry 'Results Submitted' was removed.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a comprehensive study record block (identification, design, measures, eligibility, flows, results, adverse events, quality control) with a returned date; significant for pages that track research studies, but no changes to existing content were removed.SummaryDifference3%

- Check34 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference7%

- Check41 days agoChange DetectedPage now shows that results have been submitted and the page revision has advanced to v3.1.0, replacing the previous no-results state (v3.0.2).SummaryDifference0.4%

- Check55 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.4%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.4%

Stay in the know with updates to Ertugliflozin in Pediatric T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.